http://biz.yahoo.com/prnews/060913/new028.html?.v=57
Phase II Data Showing Clinical Benefits of Novel Once-Daily Oral Multiple Sclerosis Therapy FTY720 (Fingolimod) Published in New England Journal of Medicine
http://www.forbes.com/forbeslife/hea...out534918.html
New Drug Reduces MS Symptoms